MENU
RLAY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Relay Therapeutics (RLAY) Earnings Date & Reports
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients... Show more
A.I. Advisor
published Earnings
RLAY is expected to report earnings to fall 2.83% to -39 cents per share on November 11
Q3'26
Est.
$-0.40
Q2'26
Missed
by $0.02
Q1'26
Missed
by $0.05
Q4'25
Beat
by $0.09
Q3'25
Missed
by $0.01
The last earnings report on August 06 showed earnings per share of -40 cents, missing the estimate of -38 cents. With 1.75M shares outstanding, the current market capitalization sits at 4.17B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets
Industry Biotechnology
Profile
Details
Industry
N/A
Address
60 Hampshire Street
Phone
+1 617 370-8837
Employees
192
Web
https://www.relaytx.com